CASI Pharmaceuticals, Inc. (CASI)

NASDAQ: CASI · IEX Real-Time Price · USD

5.41

+0.01 (0.19%)

At close: Jul 2, 2024, 4:00 PM

5.23

-0.18 (-3.33%)

After-hours: Jul 2, 2024, 5:14 PM EDT

CASI Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1994
Net Income	-26.96	-41.01	-36.65	-48.29	-46.03	Upgrade
Depreciation & Amortization	4.73	3.61	3.1	3.23	2.58	Upgrade
Share-Based Compensation	7.22	7.01	7.77	7.82	7.31	Upgrade
Other Operating Activities	-4.98	9.31	-1.05	11.35	12.9	Upgrade
Operating Cash Flow	-19.97	-21.09	-26.84	-25.89	-23.24	Upgrade
Capital Expenditures	-2.24	-5.47	-8.94	1.2	-7.05	Upgrade
Acquisitions	0	41.16	-5.68	-6.4	-14.04	Upgrade
Change in Investments	-7.43	-4.53	0	0	0	Upgrade
Other Investing Activities	-	-	-6.08	-15.52	-6.97	Upgrade
Investing Cash Flow	-9.67	31.16	-20.69	-20.72	-28.06	Upgrade
Share Issuance / Repurchase	-0.17	-3.27	30.48	45.9	3.75	Upgrade
Debt Issued / Paid	0	0	-0.84	1.25	-1.5	Upgrade
Other Financing Activities	-0.74	-	-	-	19.79	Upgrade
Financing Cash Flow	-0.91	-3.27	29.64	47.15	22.05	Upgrade
Exchange Rate Effect	0.52	1.6	-0.47	2.9	-1.33	Upgrade
Net Cash Flow	-30.03	8.41	-18.36	3.44	-30.58	Upgrade
Free Cash Flow	-22.21	-26.56	-35.78	-24.69	-30.3	Upgrade
Free Cash Flow Margin	-65.55%	-61.62%	-118.59%	-163.03%	-733.38%	Upgrade
Free Cash Flow Per Share	-1.66	-1.95	-2.63	-2.23	-3.16	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).